GlassScriptPhysician profile
Brittney Phipps
NPI 1548830821
$8,923.62
in general payments reported to CMS, 2019-2025
41 companies · $1,661 in 2025
The $1,661 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $685 · 2022: $1,952 · 2023: $2,881 · 2024: $1,744 · 2025: $1,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,286.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,290.51 | 2021-2025 | |
| Amgen INC. | $741.16 | 2022-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $656.78 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $461.14 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $401.86 | 2021-2025 | Rexulti |
| Glaxosmithkline, LLC. | $394.35 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $390.49 | 2022-2025 | Verquvo, Belsomra, Steglatro |
| Pfizer INC. | $375.22 | 2023-2025 | |
| Axsome Therapeutics, INC. | $304.81 | 2023-2025 | Auvelity, Sunosi |
| Lilly USA, LLC | $287.34 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Lundbeck LLC | $282.21 | 2022-2025 | Rexulti, Vyepti |
| Janssen Pharmaceuticals, INC | $268.50 | 2022-2024 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.75 | 2022-2025 | Xifaxan, Trulance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $164.79 | 2021-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $149.26 | 2022-2025 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Phipps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.